LRPPRC facilitates tumor progression and immune evasion through upregulation of m6A modification of PD-L1 mRNA in hepatocellular carcinoma
ObjectiveLRPPRC is a newly discovered N6-methyladenosine (m6A) modification reader, which potentially affects hepatocellular carcinoma (HCC) progression. PD-L1 in tumor cells is essential for tumor immune evasion. This work investigated the LRPPRC-mediated m6A-modification effect on PD-L1 mRNA and i...
Main Authors: | Houhong Wang, Amao Tang, Yayun Cui, Huihui Gong, Heng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1144774/full |
Similar Items
-
Hantavirus-Driven PD-L1/PD-L2 Upregulation: An Imperfect Viral Immune Evasion Mechanism
by: Martin J. Raftery, et al.
Published: (2018-12-01) -
LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6A modification in triple‐negative breast cancer
by: Yuanhang Yu, et al.
Published: (2024-02-01) -
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
by: Chen Chen, et al.
Published: (2023-02-01) -
A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC–OXPHOS axis
by: Ruibin Jiang, et al.
Published: (2023-07-01) -
Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular RecruitmentSummary
by: Feng Zhang, et al.
Published: (2023-01-01)